Kaken Pharmaceutical Co., Ltd.
Kaken Pharmaceutical Co., Ltd. (4521.T) Stock Competitors & Peer Comparison
See (4521.T) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 4521.T | ¥4,210.00 | +0.00% | 159.4B | 290.34 | ¥14.50 | +4.04% |
| 4502.T | ¥5,673.00 | +0.14% | 9T | 80.12 | ¥70.81 | +3.49% |
| 4507.T | ¥3,409.00 | +0.15% | 2.9T | 16.99 | ¥200.62 | +1.82% |
| 4523.T | ¥4,829.00 | +0.67% | 1.4T | 27.58 | ¥175.09 | +3.31% |
| 4506.T | ¥1,835.00 | -1.66% | 729B | 4.71 | ¥389.41 | N/A |
| 4581.T | ¥8,580.00 | -0.12% | 703.3B | 83.43 | ¥102.84 | N/A |
| 4530.T | ¥6,037.00 | -0.05% | 423B | 22.41 | ¥269.43 | +1.99% |
| 4516.T | ¥5,472.00 | +1.11% | 368.8B | 11.97 | ¥457.31 | +2.27% |
| 8129.T | ¥4,550.00 | -0.83% | 294.4B | 15.10 | ¥301.33 | +1.87% |
| 4540.T | ¥3,836.00 | -0.52% | 285.2B | 10.56 | ¥363.19 | +3.55% |
Stock Comparison
4521.T vs 4502.T Comparison March 2026
4521.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4521.T stands at 159.4B. In comparison, 4502.T has a market cap of 9T. Regarding current trading prices, 4521.T is priced at ¥4,210.00, while 4502.T trades at ¥5,673.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4521.T currently has a P/E ratio of 290.34, whereas 4502.T's P/E ratio is 80.12. In terms of profitability, 4521.T's ROE is -0.03%, compared to 4502.T's ROE of +0.02%. Regarding short-term risk, 4521.T is less volatile compared to 4502.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4521.T.Check 4502.T's competition here
4521.T vs 4507.T Comparison March 2026
4521.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4521.T stands at 159.4B. In comparison, 4507.T has a market cap of 2.9T. Regarding current trading prices, 4521.T is priced at ¥4,210.00, while 4507.T trades at ¥3,409.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4521.T currently has a P/E ratio of 290.34, whereas 4507.T's P/E ratio is 16.99. In terms of profitability, 4521.T's ROE is -0.03%, compared to 4507.T's ROE of +0.14%. Regarding short-term risk, 4521.T is less volatile compared to 4507.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4521.T.Check 4507.T's competition here
4521.T vs 4523.T Comparison March 2026
4521.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4521.T stands at 159.4B. In comparison, 4523.T has a market cap of 1.4T. Regarding current trading prices, 4521.T is priced at ¥4,210.00, while 4523.T trades at ¥4,829.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4521.T currently has a P/E ratio of 290.34, whereas 4523.T's P/E ratio is 27.58. In terms of profitability, 4521.T's ROE is -0.03%, compared to 4523.T's ROE of +0.05%. Regarding short-term risk, 4521.T is less volatile compared to 4523.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4521.T.Check 4523.T's competition here
4521.T vs 4506.T Comparison March 2026
4521.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4521.T stands at 159.4B. In comparison, 4506.T has a market cap of 729B. Regarding current trading prices, 4521.T is priced at ¥4,210.00, while 4506.T trades at ¥1,835.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4521.T currently has a P/E ratio of 290.34, whereas 4506.T's P/E ratio is 4.71. In terms of profitability, 4521.T's ROE is -0.03%, compared to 4506.T's ROE of +0.49%. Regarding short-term risk, 4521.T is less volatile compared to 4506.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4521.T.Check 4506.T's competition here
4521.T vs 4581.T Comparison March 2026
4521.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4521.T stands at 159.4B. In comparison, 4581.T has a market cap of 703.3B. Regarding current trading prices, 4521.T is priced at ¥4,210.00, while 4581.T trades at ¥8,580.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4521.T currently has a P/E ratio of 290.34, whereas 4581.T's P/E ratio is 83.43. In terms of profitability, 4521.T's ROE is -0.03%, compared to 4581.T's ROE of +0.02%. Regarding short-term risk, 4521.T is more volatile compared to 4581.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4521.T.Check 4581.T's competition here
4521.T vs 4530.T Comparison March 2026
4521.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4521.T stands at 159.4B. In comparison, 4530.T has a market cap of 423B. Regarding current trading prices, 4521.T is priced at ¥4,210.00, while 4530.T trades at ¥6,037.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4521.T currently has a P/E ratio of 290.34, whereas 4530.T's P/E ratio is 22.41. In terms of profitability, 4521.T's ROE is -0.03%, compared to 4530.T's ROE of +0.07%. Regarding short-term risk, 4521.T is more volatile compared to 4530.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4521.T.Check 4530.T's competition here
4521.T vs 4516.T Comparison March 2026
4521.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4521.T stands at 159.4B. In comparison, 4516.T has a market cap of 368.8B. Regarding current trading prices, 4521.T is priced at ¥4,210.00, while 4516.T trades at ¥5,472.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4521.T currently has a P/E ratio of 290.34, whereas 4516.T's P/E ratio is 11.97. In terms of profitability, 4521.T's ROE is -0.03%, compared to 4516.T's ROE of +0.11%. Regarding short-term risk, 4521.T is less volatile compared to 4516.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4521.T.Check 4516.T's competition here
4521.T vs 8129.T Comparison March 2026
4521.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4521.T stands at 159.4B. In comparison, 8129.T has a market cap of 294.4B. Regarding current trading prices, 4521.T is priced at ¥4,210.00, while 8129.T trades at ¥4,550.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4521.T currently has a P/E ratio of 290.34, whereas 8129.T's P/E ratio is 15.10. In terms of profitability, 4521.T's ROE is -0.03%, compared to 8129.T's ROE of +0.09%. Regarding short-term risk, 4521.T is less volatile compared to 8129.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4521.T.Check 8129.T's competition here
4521.T vs 4540.T Comparison March 2026
4521.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4521.T stands at 159.4B. In comparison, 4540.T has a market cap of 285.2B. Regarding current trading prices, 4521.T is priced at ¥4,210.00, while 4540.T trades at ¥3,836.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4521.T currently has a P/E ratio of 290.34, whereas 4540.T's P/E ratio is 10.56. In terms of profitability, 4521.T's ROE is -0.03%, compared to 4540.T's ROE of +0.10%. Regarding short-term risk, 4521.T is more volatile compared to 4540.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4521.T.Check 4540.T's competition here
4521.T vs 4887.T Comparison March 2026
4521.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4521.T stands at 159.4B. In comparison, 4887.T has a market cap of 245.6B. Regarding current trading prices, 4521.T is priced at ¥4,210.00, while 4887.T trades at ¥2,127.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4521.T currently has a P/E ratio of 290.34, whereas 4887.T's P/E ratio is 22.77. In terms of profitability, 4521.T's ROE is -0.03%, compared to 4887.T's ROE of -0.02%. Regarding short-term risk, 4521.T is less volatile compared to 4887.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4521.T.Check 4887.T's competition here
4521.T vs 4553.T Comparison March 2026
4521.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4521.T stands at 159.4B. In comparison, 4553.T has a market cap of 202.3B. Regarding current trading prices, 4521.T is priced at ¥4,210.00, while 4553.T trades at ¥4,110.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4521.T currently has a P/E ratio of 290.34, whereas 4553.T's P/E ratio is 9.80. In terms of profitability, 4521.T's ROE is -0.03%, compared to 4553.T's ROE of +0.12%. Regarding short-term risk, 4521.T is less volatile compared to 4553.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4521.T.Check 4553.T's competition here
4521.T vs 4547.T Comparison March 2026
4521.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4521.T stands at 159.4B. In comparison, 4547.T has a market cap of 186.3B. Regarding current trading prices, 4521.T is priced at ¥4,210.00, while 4547.T trades at ¥4,495.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4521.T currently has a P/E ratio of 290.34, whereas 4547.T's P/E ratio is 13.13. In terms of profitability, 4521.T's ROE is -0.03%, compared to 4547.T's ROE of +0.07%. Regarding short-term risk, 4521.T is less volatile compared to 4547.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4521.T.Check 4547.T's competition here
4521.T vs 4551.T Comparison March 2026
4521.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4521.T stands at 159.4B. In comparison, 4551.T has a market cap of 178.5B. Regarding current trading prices, 4521.T is priced at ¥4,210.00, while 4551.T trades at ¥6,350.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4521.T currently has a P/E ratio of 290.34, whereas 4551.T's P/E ratio is 33.00. In terms of profitability, 4521.T's ROE is -0.03%, compared to 4551.T's ROE of +0.04%. Regarding short-term risk, 4521.T is more volatile compared to 4551.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4521.T.Check 4551.T's competition here
4521.T vs 4534.T Comparison March 2026
4521.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4521.T stands at 159.4B. In comparison, 4534.T has a market cap of 124.6B. Regarding current trading prices, 4521.T is priced at ¥4,210.00, while 4534.T trades at ¥3,515.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4521.T currently has a P/E ratio of 290.34, whereas 4534.T's P/E ratio is 21.92. In terms of profitability, 4521.T's ROE is -0.03%, compared to 4534.T's ROE of +0.05%. Regarding short-term risk, 4521.T is less volatile compared to 4534.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4521.T.Check 4534.T's competition here
4521.T vs 4559.T Comparison March 2026
4521.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4521.T stands at 159.4B. In comparison, 4559.T has a market cap of 93.9B. Regarding current trading prices, 4521.T is priced at ¥4,210.00, while 4559.T trades at ¥2,131.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4521.T currently has a P/E ratio of 290.34, whereas 4559.T's P/E ratio is 16.74. In terms of profitability, 4521.T's ROE is -0.03%, compared to 4559.T's ROE of +0.08%. Regarding short-term risk, 4521.T is less volatile compared to 4559.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4521.T.Check 4559.T's competition here
4521.T vs 4569.T Comparison March 2026
4521.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4521.T stands at 159.4B. In comparison, 4569.T has a market cap of 93.2B. Regarding current trading prices, 4521.T is priced at ¥4,210.00, while 4569.T trades at ¥1,623.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4521.T currently has a P/E ratio of 290.34, whereas 4569.T's P/E ratio is 10.00. In terms of profitability, 4521.T's ROE is -0.03%, compared to 4569.T's ROE of +0.08%. Regarding short-term risk, 4521.T is less volatile compared to 4569.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4521.T.Check 4569.T's competition here
4521.T vs 4886.T Comparison March 2026
4521.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4521.T stands at 159.4B. In comparison, 4886.T has a market cap of 63B. Regarding current trading prices, 4521.T is priced at ¥4,210.00, while 4886.T trades at ¥2,220.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4521.T currently has a P/E ratio of 290.34, whereas 4886.T's P/E ratio is 13.21. In terms of profitability, 4521.T's ROE is -0.03%, compared to 4886.T's ROE of +0.07%. Regarding short-term risk, 4521.T is less volatile compared to 4886.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4521.T.Check 4886.T's competition here
4521.T vs 4554.T Comparison March 2026
4521.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4521.T stands at 159.4B. In comparison, 4554.T has a market cap of 54.4B. Regarding current trading prices, 4521.T is priced at ¥4,210.00, while 4554.T trades at ¥2,225.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4521.T currently has a P/E ratio of 290.34, whereas 4554.T's P/E ratio is 18.09. In terms of profitability, 4521.T's ROE is -0.03%, compared to 4554.T's ROE of +0.05%. Regarding short-term risk, 4521.T is less volatile compared to 4554.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4521.T.Check 4554.T's competition here
4521.T vs 4577.T Comparison March 2026
4521.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4521.T stands at 159.4B. In comparison, 4577.T has a market cap of 43.6B. Regarding current trading prices, 4521.T is priced at ¥4,210.00, while 4577.T trades at ¥1,473.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4521.T currently has a P/E ratio of 290.34, whereas 4577.T's P/E ratio is 19.81. In terms of profitability, 4521.T's ROE is -0.03%, compared to 4577.T's ROE of +0.04%. Regarding short-term risk, 4521.T is less volatile compared to 4577.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4521.T.Check 4577.T's competition here
4521.T vs 9273.T Comparison March 2026
4521.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4521.T stands at 159.4B. In comparison, 9273.T has a market cap of 35B. Regarding current trading prices, 4521.T is priced at ¥4,210.00, while 9273.T trades at ¥830.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4521.T currently has a P/E ratio of 290.34, whereas 9273.T's P/E ratio is 9.52. In terms of profitability, 4521.T's ROE is -0.03%, compared to 9273.T's ROE of +0.13%. Regarding short-term risk, 4521.T is less volatile compared to 9273.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4521.T.Check 9273.T's competition here
4521.T vs 4595.T Comparison March 2026
4521.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4521.T stands at 159.4B. In comparison, 4595.T has a market cap of 34.8B. Regarding current trading prices, 4521.T is priced at ¥4,210.00, while 4595.T trades at ¥1,827.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4521.T currently has a P/E ratio of 290.34, whereas 4595.T's P/E ratio is 10.53. In terms of profitability, 4521.T's ROE is -0.03%, compared to 4595.T's ROE of +0.20%. Regarding short-term risk, 4521.T is less volatile compared to 4595.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4521.T.Check 4595.T's competition here
4521.T vs 4538.T Comparison March 2026
4521.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4521.T stands at 159.4B. In comparison, 4538.T has a market cap of 20.8B. Regarding current trading prices, 4521.T is priced at ¥4,210.00, while 4538.T trades at ¥2,432.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4521.T currently has a P/E ratio of 290.34, whereas 4538.T's P/E ratio is -5.21. In terms of profitability, 4521.T's ROE is -0.03%, compared to 4538.T's ROE of +0.06%. Regarding short-term risk, 4521.T is less volatile compared to 4538.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4521.T.Check 4538.T's competition here
4521.T vs 2929.T Comparison March 2026
4521.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4521.T stands at 159.4B. In comparison, 2929.T has a market cap of 17.9B. Regarding current trading prices, 4521.T is priced at ¥4,210.00, while 2929.T trades at ¥619.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4521.T currently has a P/E ratio of 290.34, whereas 2929.T's P/E ratio is 48.25. In terms of profitability, 4521.T's ROE is -0.03%, compared to 2929.T's ROE of -0.17%. Regarding short-term risk, 4521.T is less volatile compared to 2929.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4521.T.Check 2929.T's competition here
4521.T vs 4574.T Comparison March 2026
4521.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4521.T stands at 159.4B. In comparison, 4574.T has a market cap of 14.7B. Regarding current trading prices, 4521.T is priced at ¥4,210.00, while 4574.T trades at ¥293.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4521.T currently has a P/E ratio of 290.34, whereas 4574.T's P/E ratio is -5.90. In terms of profitability, 4521.T's ROE is -0.03%, compared to 4574.T's ROE of +0.11%. Regarding short-term risk, 4521.T is more volatile compared to 4574.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4521.T.Check 4574.T's competition here
4521.T vs 4512.T Comparison March 2026
4521.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4521.T stands at 159.4B. In comparison, 4512.T has a market cap of 11.6B. Regarding current trading prices, 4521.T is priced at ¥4,210.00, while 4512.T trades at ¥335.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4521.T currently has a P/E ratio of 290.34, whereas 4512.T's P/E ratio is 161.06. In terms of profitability, 4521.T's ROE is -0.03%, compared to 4512.T's ROE of +0.03%. Regarding short-term risk, 4521.T is less volatile compared to 4512.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4521.T.Check 4512.T's competition here
4521.T vs 4524.T Comparison March 2026
4521.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4521.T stands at 159.4B. In comparison, 4524.T has a market cap of 9.4B. Regarding current trading prices, 4521.T is priced at ¥4,210.00, while 4524.T trades at ¥2,301.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4521.T currently has a P/E ratio of 290.34, whereas 4524.T's P/E ratio is 16.19. In terms of profitability, 4521.T's ROE is -0.03%, compared to 4524.T's ROE of +0.05%. Regarding short-term risk, 4521.T is more volatile compared to 4524.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4521.T.Check 4524.T's competition here
4521.T vs 4597.T Comparison March 2026
4521.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4521.T stands at 159.4B. In comparison, 4597.T has a market cap of 8.4B. Regarding current trading prices, 4521.T is priced at ¥4,210.00, while 4597.T trades at ¥32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4521.T currently has a P/E ratio of 290.34, whereas 4597.T's P/E ratio is -3.57. In terms of profitability, 4521.T's ROE is -0.03%, compared to 4597.T's ROE of -0.62%. Regarding short-term risk, 4521.T is less volatile compared to 4597.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4521.T.Check 4597.T's competition here
4521.T vs 7079.T Comparison March 2026
4521.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4521.T stands at 159.4B. In comparison, 7079.T has a market cap of 6.5B. Regarding current trading prices, 4521.T is priced at ¥4,210.00, while 7079.T trades at ¥2,696.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4521.T currently has a P/E ratio of 290.34, whereas 7079.T's P/E ratio is 8.85. In terms of profitability, 4521.T's ROE is -0.03%, compared to 7079.T's ROE of +0.16%. Regarding short-term risk, 4521.T is less volatile compared to 7079.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4521.T.Check 7079.T's competition here
4521.T vs 4586.T Comparison March 2026
4521.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4521.T stands at 159.4B. In comparison, 4586.T has a market cap of 6.4B. Regarding current trading prices, 4521.T is priced at ¥4,210.00, while 4586.T trades at ¥108.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4521.T currently has a P/E ratio of 290.34, whereas 4586.T's P/E ratio is -8.08. In terms of profitability, 4521.T's ROE is -0.03%, compared to 4586.T's ROE of -0.48%. Regarding short-term risk, 4521.T is less volatile compared to 4586.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4521.T.Check 4586.T's competition here
4521.T vs 4539.T Comparison March 2026
4521.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4521.T stands at 159.4B. In comparison, 4539.T has a market cap of 6.3B. Regarding current trading prices, 4521.T is priced at ¥4,210.00, while 4539.T trades at ¥1,738.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4521.T currently has a P/E ratio of 290.34, whereas 4539.T's P/E ratio is 12.47. In terms of profitability, 4521.T's ROE is -0.03%, compared to 4539.T's ROE of +0.03%. Regarding short-term risk, 4521.T is more volatile compared to 4539.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4521.T.Check 4539.T's competition here
4521.T vs 4892.T Comparison March 2026
4521.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4521.T stands at 159.4B. In comparison, 4892.T has a market cap of 5.2B. Regarding current trading prices, 4521.T is priced at ¥4,210.00, while 4892.T trades at ¥620.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4521.T currently has a P/E ratio of 290.34, whereas 4892.T's P/E ratio is -6.14. In terms of profitability, 4521.T's ROE is -0.03%, compared to 4892.T's ROE of -0.30%. Regarding short-term risk, 4521.T is less volatile compared to 4892.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4521.T.Check 4892.T's competition here
4521.T vs 4582.T Comparison March 2026
4521.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4521.T stands at 159.4B. In comparison, 4582.T has a market cap of 5.2B. Regarding current trading prices, 4521.T is priced at ¥4,210.00, while 4582.T trades at ¥107.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4521.T currently has a P/E ratio of 290.34, whereas 4582.T's P/E ratio is -1.12. In terms of profitability, 4521.T's ROE is -0.03%, compared to 4582.T's ROE of -2.20%. Regarding short-term risk, 4521.T is less volatile compared to 4582.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4521.T.Check 4582.T's competition here
4521.T vs 4883.T Comparison March 2026
4521.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4521.T stands at 159.4B. In comparison, 4883.T has a market cap of 4.5B. Regarding current trading prices, 4521.T is priced at ¥4,210.00, while 4883.T trades at ¥58.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4521.T currently has a P/E ratio of 290.34, whereas 4883.T's P/E ratio is -2.85. In terms of profitability, 4521.T's ROE is -0.03%, compared to 4883.T's ROE of -0.72%. Regarding short-term risk, 4521.T is less volatile compared to 4883.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4521.T.Check 4883.T's competition here
4521.T vs 4541.T Comparison March 2026
4521.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4521.T stands at 159.4B. In comparison, 4541.T has a market cap of 2.5B. Regarding current trading prices, 4521.T is priced at ¥4,210.00, while 4541.T trades at ¥35.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4521.T currently has a P/E ratio of 290.34, whereas 4541.T's P/E ratio is -0.00. In terms of profitability, 4521.T's ROE is -0.03%, compared to 4541.T's ROE of +0.13%. Regarding short-term risk, 4521.T is less volatile compared to 4541.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4521.T.Check 4541.T's competition here